As a medical student, do you ever wonder what its like to specialize in academic family medicine? Meet AMA member Rambod A. Rouhbakhsh, MD, a featured academic family physician in the AMAsShadow Me Specialty Series, which offers advice directly from physicians about life in their specialties. Check out his insights to help determine whether a career in academic family medicine and preventive medicine might be a good fit for you.
The AMAsSpecialty Guidesimplifies medical students specialty selection process, highlight major specialties, detail training information, and provide access to related association information. It is produced byFREIDA, the AMA Residency & Fellowship Database.
Learn more with the AMA about family medicine and preventive medicine.
Shadowing Dr. Rouhbakhsh
Specialty: Family medicine; occupational and environmental medicine.
Practice setting: Academic family medicine residency; clinical research.
Years in practice:17.
A typical day and week in my practice: My days are split into discreet roles. Mondays are my teaching days. Tuesdays are recruitment and admin days. Wednesdays are program and institutional development days. Thursdays and Fridays are my clinical research days.
My day typically starts with a morning report at 7:30 a.m. and formally ends at 5 p.m. Informally, I find most of my meaningful work is done after hours. Now that I am in a leadership position, I rarely find quiet time to actually create a work product. As such, I tend to be most productive during my boys soccer practice when I can sit in my car and work on the computer.
How the year unfolds in my practice: When I began my career in academic family medicine, I started as clinical faculty, so my work revolved primarily around teaching residents in clinic. Now, as the program director, I spend more time doing administrative work, which translates to meetings, recruiting new residents, and developing faculty.
The year for us begins in July when we welcome our new residents. The interns spend much of July in orientation, during which we help them transition from medical student to resident physician. We organize orientation activities, compose introductory didactics, and help ease our interns into their new jobs. Also in July, we transition our new PGY-2 residents to senior residents who take on teaching and supervisory responsibilities for our new interns.
In August, we start prepping for recruitment season, which officially kicks off when we receive ERAS applications in September. We also tend to do outreach talks to our local medical schools in August and September. From early October through December, we interview prospective students and find matches for our residency program. We receive thousands of applications from medical students, but we only offer interviews to 60 applicants. To arrive at that point, we spend a significant portion of September reading applications.
October through December is dominated by the actual interviews. In pre-COVID times, these were more festive events with dinners and lunches. Now that they are virtual, it is less time-consuming, but also less fun. Throughout the fall and winter, we focus on our graduating PGY-3 residents to make sure they have met their requirements and assist them in finding jobs.
In January, faculty have more time to meet, and this is when we do cumulative evaluations of our residents and engage in program enhancement activities. We typically elect a chief resident for the upcoming year during this time. January through March is also when we spend extra time on research and academic projects.
Then in March we get our Match list. We welcome our incoming residents and start prepping them for orientation in July. Most of our focus in the spring is on our graduating senior residents. We organize wellness activities and plan for graduation. We also do our year-end cumulative evaluations for residents, faculty, and the program itself in late spring.
Interspersed throughout the academic year, we teach in clinic, in hospital, and during didactics. There are also myriad committee meetings and ad-hoc opportunities and issues that arise. For instance, new research collaborations frequently occur since we are literally across the street from the University of Southern Mississippi and across town from William Carey University. These opportunities are exciting, but sometimes they stretch our bandwidth.
The most challenging and rewarding aspects of academic family medicine: Teaching is fantastic, especially teaching residents. These young doctors are on the top tier of the education hierarchy. They are typically the smartest people I know, and I feel privileged to help them attain their post-graduate training. These are intelligent, motivated people who approach education with vigor and enthusiasm.
They are also inquisitive enough to challenge and grow my personal fund of knowledge. If there is something that we dont know collectively, residents will research it and come back to teach the entire group. These are high-powered education machines who can accomplish seemingly anything they put their minds to.
Academic family medicine is exceedingly rewarding, not just because it involves teaching, but because academic family medicine can be situated in community-based hospitals, allowing you greater flexibility to live where you wish. For example, if I had wanted to do academic neurosurgery or cardiology, I would have to be in the one medical school in Mississippi which is in Jackson.
Community-based family medicine residency programs are the bulk of academic family medicine. I am truly grateful for that because it allows me to live in a great place like Hattiesburg and not necessarily in a metropolitan area. Teaching is a remarkable joy, and I would encourage anyone who enjoys that to consider academic family medicine.
How life in academic family medicine has been affected by the global pandemic: Some of the societal effects of the pandemic have actually helped us. Being able to conduct virtual interviews with our program applicants has allowed us to draw more people and has provided us the opportunity to do more interviews in a less time-intensive and less costly way.
For example, we interviewed a woman from Ohio last year, and Im quite certain she wouldnt have flown to Mississippi for the interview. And she ended up being a match for our program, which has been fantastic for us. Also, we are now telemedicine-savvy practitioners, which is here to stay. Lastly, it has forced us to become better epidemiologists, virologists, and occupational hygienists.
How my lifestyle matches, or differs from, what I had envisioned: My life today is very different than my days as a clinical doctor. The hours are about the same, but the pace is different. My work is cognitively more challenging in academics, but it is less intense. When I was in clinic every day, I felt a rush of intensity that for me was requisite to be an efficient clinician. I dont feel that as often now. As a clinic doctor, I felt like a sprinter. Now, I feel a bit more like a marathon runnerespecially during meeting-heavy days.
Additionally, I do clinical research and run clinical trials for three half-days per week. As the principal investigator, I supervise sub-investigators, review charts, and see our trial patients. We have several ongoing trials, including COVID-19 vaccine trials, a meningococcal vaccine trial, a hypertension medication trial, a diabetes medication trial, and a pediatric migraine trial. Keeping all the protocols straight can be challenging, but it is not as intensive as a typical family medicine clinic day.
Books every medical student interested in family medicine should be reading:
The online resource students interested in family medicine should follow: My number one recommendation is UpToDate. It is the most comprehensive reference source I know of. I also suggest students sign up for recurring news that is delivered to their inbox regularly. My favorites are the New England Journal of Medicines Journal Watch, the AMAs Morning Rounds Daily, and the American Academy of Family Physicians Family Medicine Smart Brief.
Quick insights I would give students who are considering family medicine: The gift of family medicineand the curse to a degreeis its flexibility and its breadth. It can be daunting to feel like you havent mastered one aspect of the specialty. However, it is an evergreen challenge and provides enormous opportunities. It led me to preventive and occupational medicine and ultimately to academic family medicine. Family medicine is like a pluripotent stem cellit has limitless potential.
In family medicine, you can become whatever you want to become. It gives you sufficient background to discover your passions, which sometimes may be being a true generalist and having your hand in everything all the time. In that way, this specialty is extremely rewarding because it gives you the most tools to take care of the largest group of people in the most practical way.
When the pandemic broke out, my background in family medicine allowed me to dig deep into studying COVID-19. Again, its this type of training that allows you to go down these pathways with relative ease because you are so broadly trained.
Mantra or song to describe life in family medicine: At the beginning of my career, I would have to say Hustlin, by Rick Ross. Now, in midcareer, I cant think of a song. But I do have a mantra. I try to remind myself of the wisdom of impermanence: Everything changes.
Read more from the original source:
- Wealth of Newer Treatment Options Span the Scope of Multiple Myeloma and Amyloidosis - OncLive - January 16th, 2022
- Trial of Cell Therapy to Raise HbF Levels Showing Potential, But... - Sickle Cell Anemia News - January 16th, 2022
- The Fusion of mRNA and Immunotherapy - NEO.LIFE - January 16th, 2022
- Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference - The Bakersfield Californian - January 11th, 2022
- BioCardia Announces Participation at the Upcoming Digital Medicine & Medtech Showcase and the H.C. Wainwright BioConnect Virtual Conference -... - January 11th, 2022
- Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR - Yahoo Finance - January 11th, 2022
- Houston TX Diabetes Stem Cell Treatment Regenerative Medicine Therapy Launch - Digital Journal - January 9th, 2022
- Stem Cell Rejuvenation Center - January 9th, 2022
- Cartesian Aims to Propel RNA Cell Therapy with Combinations - BioSpace - January 9th, 2022
- Orthopedic Biomaterials Product Market: Hip implant product segment is anticipated to carry major share of the market - BioSpace - January 9th, 2022
- Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings - Business Wire - January 9th, 2022
- Jakubowiak Talks Daratumumab Quadruplet Therapy and the GRIFFIN Study at 2021 ASH - Cancer Network - January 9th, 2022
- Part 1: Benefit Shown With Transplant and Combination Therapy in Multiple Myeloma - Targeted Oncology - January 9th, 2022
- Notch Therapeutics' Peter Zandstra Appointed to the Order of Canada - Yahoo Finance - January 7th, 2022
- FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVirs Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults... - January 7th, 2022
- BlueRock Therapeutics Announces Closeout of First Cohort in Phase 1 Trial in Patients with Advanced Parkinson's Disease - Yahoo Finance - January 7th, 2022
- Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy - Galveston County... - January 7th, 2022
- US FDA approves Phase 3 Study Design for Zilovertamab in the Treatment of Mantle Cell Lymphoma - OncoZine - January 5th, 2022
- Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases - PRNewswire - January 5th, 2022
- FDA Grants Regenerative Medicine Advanced Therapy Designation To AlloVir's Posoleucel For The Treatment Of Adenovirus Infections In Adults And... - January 5th, 2022
- Protecting people with cancer from COVID-19: - EurekAlert - January 5th, 2022
- Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual JP Morgan Healthcare Conference - TheNewswire.ca - January 5th, 2022
- Placental Stem Cell Therapy Market to Surpass US$ 4.4 Bn by 2030, Underpinned by Enormous R&D in Cellular Therapies and Regenerative Medicine, Finds... - January 3rd, 2022
- LifeBank Chain Announces Upcoming Gene and Cell Collaboration Platform With Disrupt Blockchain Technologies - AsiaOne - January 3rd, 2022
- Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity - News-Medical.Net - January 3rd, 2022
- lodie Yung plunges into the undocumented underworld in 'The Cleaning Lady' - Entertainment Weekly News - January 3rd, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 2nd, 2022
- Curi Bio Closes $10M Series A in Oversubscribed Round - BioSpace - December 31st, 2021
- Bring in the bulldozers: Cynatas CEO on how heavyweight FujiFilm will turbocharge its ... - Stockhead - December 31st, 2021
- Questions on Quadruplets and CAR T Set to be Answered As Myeloma Paradigm Parses Out the Clinical Value of MRD - OncLive - December 31st, 2021
- Stem Cell Therapy NYC, Regenerative Medicine Injections ... - December 29th, 2021
- James Shapiro, MD: Insulin Production In T1D Patients After Stem Cell Therapy - MD Magazine - December 29th, 2021
- Global Automated and Closed Cell Therapy Processing Systems - GlobeNewswire - December 29th, 2021
- Bill would pave way for organ donation - Stabroek News - December 29th, 2021
- Celularity Receives Fast Track Designation from US FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML - BioSpace - December 29th, 2021
- Valemetostat New Drug Application Submitted in Japan for Treatment of Patients with Adult T-Cell Leukemia/Lymphoma - Business Wire - December 29th, 2021
- 2021: The Year in Diabetes - Healthline - December 29th, 2021
- Covid infects kidneys and leads to scarring: Study - India New England - December 29th, 2021
- Fetal Gut May Have Insulin-Producing Cells That Shut Off at Birth - Medscape - December 29th, 2021
- Brem Looks at Multiple Treatments for Patients With DLBCL - Targeted Oncology - December 26th, 2021
- Delete Blood Cancer! How Content Creator Duo Abhi And Niyu Inspired Thousands To Give Someone Second... - The Logical Indian - December 25th, 2021
- The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still - The Lancet - December 25th, 2021
- Ropinirole Proves Safe and Tolerable for Patients With ALS - Medscape - December 25th, 2021
- Major international research center may drive the development of future stem cell-based treatments - News-Medical.Net - December 19th, 2021
- Receiving CAR-T therapy sooner improves lymphoma survival, according to study published in New England Journal of Medicine - Newswise - December 19th, 2021
- Latest Cancer Research: CAR T to Liquid Biopsies - Healthline - December 19th, 2021
- Trials of stem cell therapy offer hope to childless women in Bangladesh - The Financial Express BD - December 19th, 2021
- UC San Diego Breaks Ground on Revitalization of Hillcrest Campus - UC San Diego Health - December 19th, 2021
- BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition -... - December 19th, 2021
- CAR-T Cell Therapy Continues to Impress in Myeloma Treatment - Curetoday.com - December 17th, 2021
- CAR-T therapy trials show promise for earlier use in lymphoma - BioPharma Dive - December 17th, 2021
- Cedars-Sinai researchers discover growth hormone in the colon that influences aging process - News-Medical.Net - December 17th, 2021
- Cyteir Therapeutics Announces the Appointment of Dr. Jeffrey S. Humphrey to Board of Directors - Business Wire - December 17th, 2021
- BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin's Fast Onset Mechanism of Action in the Prevention of... - December 17th, 2021
- CAR T-Cell Therapy for Large B-Cell Lymphoma Who, When, and How? | NEJM - nejm.org - December 15th, 2021
- Fate Therapeutics Highlights Positive Durability of Response Data from FT516 Phase 1 Study for B-cell Lymphoma and Announces FDA Regenerative Medicine... - December 15th, 2021
- AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders -... - December 15th, 2021
- Bioengineered skin breakthrough to revolutionise burns treatment - Medicine, Nursing and Health Sciences - Monash University - December 15th, 2021
- In Patients With Acute GVHD, First-Line Itolizumab Associated With High Rates of Clinical Response, Tolerability - Targeted Oncology - December 15th, 2021
- BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's Phase 3 Study for ALS in Muscle and Nerve - BioSpace - December 15th, 2021
- Flawed genetic switches could be at the origin of malformations or developmental diseases - News-Medical.net - December 15th, 2021
- BrainStorm Cell Therapeutics and Catalent Announce Completion of Technology Transfer for NurOwn Manufacturing - BioSpace - December 9th, 2021
- Syrian refugee is thriving five years after last-gasp gene therapy - STAT - STAT - December 9th, 2021
- What happened to Dolly the sheep? How long the first cloned adult mammal lived, and her legacy explained - iNews - December 9th, 2021
- It is imperative to reduce the cost of cancer treatment: Ramesh Ramadurai, MD, 3M India - ETHealthworld.com - December 9th, 2021
- For the 2nd time listed as the World's Top 2% scientists by Stanford University - Malaysiakini - December 9th, 2021
- Research offers a phylogenetic and ontogenetic overview of the primitive streak - News-Medical.net - December 7th, 2021
- New discoveries make steps toward lipoedema diagnosis and treatment - Mirage News - December 7th, 2021
- With its Parkinsons treatment, TreeFrog Therapeutics shows cell therapy is no longer science fiction - The Times Hub - December 7th, 2021
- The lung game: is hyperbaric oxygen therapy any good? - Financial Times - December 7th, 2021
- Irving Weissman Laboratory | Institute for Stem Cell ... - December 4th, 2021
- Nine Things To Know About Stem Cell Treatments - A Closer ... - December 4th, 2021
- Regenerative Medicine & Stem Cell Therapy Las Vegas ... - December 4th, 2021
- World AIDS Day: is a cure for HIV finally in sight? - Thomson Reuters Foundation - December 4th, 2021
- New genetic technology for gene expression analysis of cancer cells - News-Medical.net - December 4th, 2021
- Stem Cell Therapy Restores Insulin Production in Patients with Type 1 Diabetes - MD Magazine - December 4th, 2021
- It takes guts to make a heart - EurekAlert - December 4th, 2021
- Appia Bio Announces Appointment of Irving Weissman, MD, and Mark Exley, PhD, to Scientific Advisory Board - BioSpace - December 4th, 2021
- The Intramural Research Program at the Abu Dhabi Stem Cell Center (ADSCC) Signs a Letter of Intent to Collaborate with the Division of Intramural... - December 4th, 2021
- TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and Exposition - GlobeNewswire - December 4th, 2021